Pfizer Inc.

Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine

Moderna seeks U.S. FDA approval for booster shot aimed at Omicron subvariants

EU regulator to discuss Moderna, Pfizer Omicron vaccine applications

Pfizer COVID-19 shots appear 73% effective in children under 5

Pfizer seeks approval of updated COVID vaccine booster for fall

Coronavirus Update: Health Canada approves Pfizer’s COVID-19 booster shot for children between ages 5 and 11

Health Canada approves Pfizer’s COVID-19 booster shot for children between ages of 5 and 11

Plaintiff in first Zantac lawsuit set for trial drops case

Pfizer CEO Albert Bourla shows mild symptoms after testing positive for COVID-19

EU regulator begins review of Pfizer-BioNTech’s variant-adapted COVID-19 shot

BioNTech reports strong first half, expects demand to grow

Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4-billion deal

Pfizer leaves COVID-19 product forecast unchanged, shares fall

Africa CDC signs deal with Pfizer for COVID-19 treatment pill

U.S. FDA allows pharmacists to prescribe Pfizer’s COVID-19 pill

U.S. regulators have committed to updating COVID-19 vaccines for fall boosters, but will they arrive in time?

‘A little pinch, but it was OK‘: Elmo, 3, joins youngest Americans in getting COVID-19 vaccine

Coronavirus Update: U.S. FDA will decide on redesigned COVID-19 vaccines by early July

Pfizer says tweaked COVID-19 vaccines boost Omicron protection